• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-SURVIVIN

SURVIVIN Monoclonal Antibody for WB, IHC, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

WB, IHC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

3B9H7

N° de cat : 66495-1-PBS

Synonymes

BIRC5, IAP4, EPR 1, BIRC 5, Baculoviral IAP repeat-containing protein 5



Informations sur le produit

66495-1-PBS cible SURVIVIN dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène SURVIVIN Protéine recombinante Ag20958
Nom complet baculoviral IAP repeat-containing 5
Masse moléculaire calculée 16 kDa
Poids moléculaire observé 18 kDa
Numéro d’acquisition GenBankBC008718
Symbole du gène Survivin
Identification du gène (NCBI) 332
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Survivin, also called BIRC5, is a unique member of the inhibitor of apoptosis (IAP) protein family. Survivin is a 16 kDa anti-apoptotic protein highly expressed during fetal development and cancer cell malignancy, but is completely absent in terminally differentiated cells. The differential expression of survivin in cancer versus normal tissues makes it a useful tool in cancer diagnosis and a promising therapeutic target. Survivin expression is also highly regulated by the cell cycle and is only expressed in the G2-M phase. It is known that survivin localizes to the mitotic spindle by interaction with tubulin during mitosis and may play a contributing role in regulating mitosis. Disruption of survivin-microtubule interactions results in loss of survivin's anti-apoptosis function and increased caspase-3 activity, a mechanism involved in cell death, during mitosis. It also is a direct target gene of the Wnt pathway and is upregulated by beta-catenin.

{{ptg:RelatedPrimaryAntibodies}}